AbbVie Inc. against Eli Lilly and Company — live side-by-side technical comparison.
Prices as of 2026-09-23T20:03:50+00:00 UTC · updates daily
ABBV leads 4 of the 5 windows we measure — over 1 month ABBV is +0.2% and LLY -7.7%; over year to date ABBV is +16.0% and LLY +7.1%. The ABBV/LLY price ratio stands at 0.2303, above its 50-day average of 0.2181, and above the 200-day average of 0.2159. A ratio above its own average means ABBV is gaining on LLY; on this reading the recent edge belongs to ABBV.
| ABBV | LLY | |
|---|---|---|
| Price | $265.08 | $1150.99 |
| 1 day | -0.1%lead | -1.6% |
| 5 days | +1.0% | +1.2%lead |
| 1 month | +0.2%lead | -7.7% |
| 6 months | +29.4%lead | +26.4% |
| Year to date | +16.0%lead | +7.1% |
| 52-week position | 95% of range | 76% of range |
| 52-week range | $190.75–$269.39 | $712.05–$1292.65 |
| vs 50-day average | above $256.43 | below $1176.62 |
| vs 200-day average | above $230.16 | above $1068.31 |
| RSI (14) | 55 | 46 |
| Next earnings | 2026-10-29 | 2026-10-29 |
ABBV trades at $265.08, above its 50-day average of $256.43, and above the 200-day at $230.16. It sits at 95% of its 52-week range ($190.75–$269.39); 14-day RSI is 55, in neutral territory; an average session moves it about 2.1%. For levels, the first level overhead is $265.97 (0.3% away) and the first support below is $262.28 (1.1% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
LLY trades at $1,150.99, below its 50-day average of $1,176.62, and above the 200-day at $1,068.31. It sits at 76% of its 52-week range ($712.05–$1,292.65); 14-day RSI is 46, in neutral territory; an average session moves it about 2.4%. For levels, the first level overhead is $1,176.62 (2.2% away) and the first support below is $1,150.00 (0.1% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
LLY is the more volatile of the two — an average session moves it 2.4% against 2.1% for ABBV, so an identical position size carries roughly 1.1× the daily risk.
The comparison turns on those levels: ABBV clearing $265.97 or losing $262.28; LLY clearing $1,176.62 or losing $1,150.00. Until one of them gives way, the relative reading above stands.